RMG Global wraps up biopharma fund at $64 mln
RMG Global has closed its biopharma investment fund at $64 million. The fund is focused on biotherapeutics developed within the Israel-based FutuRx incubator, established by OrbiMed Israel, Johnson & Johnson Innovation and Takeda Ventures in cooperation with the Israel Innovation Authority.